HEATHER MILLER: Open Payments
NPI 1396072120 · CAPE GIRARDEAU, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,306 in 125 payments from 19 companies in 2025. Trend: 2023 $3,996 · 2024 $3,258 · 2025 $3,306
Food & beverage: $3,117Education: $189
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 14 | $426 |
| ABBVIE INC. | 24 | $413 |
| UCB, Inc. | 9 | $366 |
| Novartis Pharmaceuticals Corporation | 14 | $262 |
| GENZYME CORPORATION | 7 | $257 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 7 | $244 |
| Lilly USA, LLC | 6 | $243 |
| E.R. Squibb & Sons, L.L.C. | 17 | $233 |
| Madrigal Pharmaceuticals | 1 | $138 |
| Novo Nordisk Inc | 1 | $125 |
Products named: TREMFYA, Bimzelx, RINVOQ, DUPIXENT, SKYRIZI, COSENTYX, REZDIFFRA, Wegovy.
Industry payments across MO — which companies pay providers there.
